Smolen JS - Search Results

1

Baricitinib in Patients with Refractory Rheumatoid Arthritis.

Genovese MC, Kremer J, Zamani O, Ludivico C, Krogulec M, Xie L, Beattie SD, Koch AE, Cardillo TE, Rooney TP, Macias WL, de Bono S, Schlichting DE, Smolen JS. Genovese MC, et al. Among authors: smolen js. N Engl J Med. 2016 Mar 31;374(13):1243-52. doi: 10.1056/NEJMoa1507247. N Engl J Med. 2016. PMID: 27028914 Free article. Clinical Trial.

2

Efficacy and safety of the new DMARD leflunomide: comparison to placebo and sulfasalazine in active rheumatoid arthritis.

Smolen JS. Smolen JS. Scand J Rheumatol Suppl. 1999;112:15-21. doi: 10.1080/030097499750042245-1. Scand J Rheumatol Suppl. 1999. PMID: 10668523 Clinical Trial.

3

Development of a disease activity index for the assessment of reactive arthritis (DAREA).

Eberl G, Studnicka-Benke A, Hitzelhammer H, Gschnait F, Smolen JS. Eberl G, et al. Among authors: smolen js. Rheumatology (Oxford). 2000 Feb;39(2):148-55. doi: 10.1093/rheumatology/39.2.148. Rheumatology (Oxford). 2000. PMID: 10725064

4

Efficacy and safety of leflunomide in active rheumatoid arthritis.

Smolen JS, Emery P. Smolen JS, et al. Rheumatology (Oxford). 2000 Jun;39 Suppl 1:48-56. doi: 10.1093/oxfordjournals.rheumatology.a031495. Rheumatology (Oxford). 2000. PMID: 11001380

5

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN; Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Lipsky PE, et al. Among authors: smolen js. N Engl J Med. 2000 Nov 30;343(22):1594-602. doi: 10.1056/NEJM200011303432202. N Engl J Med. 2000. PMID: 11096166 Free article. Clinical Trial.

6

Autoantigen microarrays for multiplex characterization of autoantibody responses.

Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, Dean EJ, Fournel S, Fong D, Genovese MC, de Vegvar HE, Skriner K, Hirschberg DL, Morris RI, Muller S, Pruijn GJ, van Venrooij WJ, Smolen JS, Brown PO, Steinman L, Utz PJ. Robinson WH, et al. Among authors: smolen js. Nat Med. 2002 Mar;8(3):295-301. doi: 10.1038/nm0302-295. Nat Med. 2002. PMID: 11875502

7

Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysis.

Aletaha D, Smolen JS. Aletaha D, et al. Among authors: smolen js. Arthritis Rheum. 2002 Apr 15;47(2):181-8. doi: 10.1002/art.10266. Arthritis Rheum. 2002. PMID: 11954012 Free article.

8

Practical progress in realisation of early diagnosis and treatment of patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years.

Aletaha D, Eberl G, Nell VP, Machold KP, Smolen JS. Aletaha D, et al. Among authors: smolen js. Ann Rheum Dis. 2002 Jul;61(7):630-4. doi: 10.1136/ard.61.7.630. Ann Rheum Dis. 2002. PMID: 12079906 Free PMC article.

9

Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational study.

Aletaha D, Smolen JS. Aletaha D, et al. Among authors: smolen js. J Rheumatol. 2002 Aug;29(8):1631-8. J Rheumatol. 2002. PMID: 12180721

10

The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.

Aletaha D, Smolen JS. Aletaha D, et al. Among authors: smolen js. Rheumatology (Oxford). 2002 Dec;41(12):1367-74. doi: 10.1093/rheumatology/41.12.1367. Rheumatology (Oxford). 2002. PMID: 12468815

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

823 results

Search Page